AMBI Incorporated

AMBI Incorporated concentrates its business primarily on research, development, manufacturing, and sales of Nutrition Products. The Company supports the value of its Nutrition Products with "pharmaceutical-type" clinical trials. The Company's Nutrition Products are developed for consumers concerned primarily about cardiovascular health and diabetes.

Contact Details: 4 Manhattenville Road Purchase NY 10577-2197 United States of America Tel: 914 701 4500 Fax: 914 696-0860 Email: mail@ambiinc.com WWW: www.ambiinc.com/

Loading...

Recent Publications by AMBI Incorporated:
Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists. Peripheral administration of the endogenous Y(2) and Y(4) receptor...	14th April, 2007	Department of Surgery, University of Cincinnati Medical Center,	Peptides. 2007 Feb;28(2):235-40. Epub 2007 Jan 3. DOI Direct Link
Ghrelin stimulates food intake and growth hormone release in rats with thermal injury: synthesis of ghrelin. Ghrelin, a 28-residue octanoylated peptide recently isolated from the...	29th September, 2006	Department of Surgery, University of Cincinnati College of Medicine, PO	Peptides. 2006 Jul;27(7):1624-31. Epub 2006 Mar 30. DOI Direct Link
Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. The identification of stem cell-specific proteins and the elucidation of...	1st July, 2006	Academic Rheumatology, Department of Clinical Science at North Bristol,	Stem Cells. 2006 Apr;24(4):1113-20. Epub 2005 Nov 10. DOI Direct Link
Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. We have previously shown [Cys-Trp-Arg-Nva-Arg-Tyr-NH(2)](2), 1, to be a...	23rd May, 2006	Division of Gastrointestinal Hormones, Department of Surgery and	J Med Chem. 2006 Apr 20;49(8):2661-5. DOI Direct Link
Production logistics of 177Lu for radionuclide therapy. Owing to its favourable decay characteristics 177Lu [T(1/2)=6.71 d,...	3rd December, 2003	Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai 400	Appl Radiat Isot. 2003 Aug-Sep;59(2-3):109-18.
→View more AMBI Incorporated research publications.

BioNews Results for AMBI Incorporated:
'Elite' HIV wife may hold secret to AIDS vaccine	Yahoo! India:  Aug 13 2008 1:31AM Matching: ambi
Neuro-Hitech acquires MCR American Pharmaceuticals	Pharmaceutical Business Review:  Jun 13 2008 4:28PM Matching: ambi

AMBI Incorporated Patents:
US Patent No.	Title
7328697	Radiant tube heater assembly
5914326	Method for promoting weight and fat loss
5910479	Method for the treatment of Streptococcus pneumoniae infection
5905075	Chromium nicotinate compositions and uses thereof
5866539	Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
→View more AMBI Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 403 times since April 2007, the link to the organisation's website has been followed 83 times

Recent Search Terms used to find this page: 4 manhattenville road | ambi pharm | ambi antibiotic | results for Ambi | ambi incorporated | treatment of streptococcus pneumoniae | .

Search for more companies in Purchase

Search for more companies in NY

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AMBI Incorporated